• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IQN
Click for more information
0.00% 64.0¢

iQnovate Limited - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
IQN IQNovate Half Yearly Report (Price Sensitive) PRICE SENSITIVE18/03/19
IQN Price Query (Price Sensitive) PRICE SENSITIVE12/12/18
IQN Response to Price Query (Price Sensitive) PRICE SENSITIVE12/12/18
IQN General Market Disclosure (Price Sensitive) PRICE SENSITIVE28/11/18
IQN Results of Meeting27/11/18
IQN Chairman's Address26/11/18
IQN Update to Scheme Implementation Dates19/11/18
IQN Notice of 2018 AGM26/10/18
IQN 2018 Annual Report (Price Sensitive) PRICE SENSITIVE30/09/18
IQN Application for Securities20/09/18
IQN Private Placement (Price Sensitive) PRICE SENSITIVE19/09/18
IQN 2018 Preliminary Final Results & Financial Statements (Price Sensitive) PRICE SENSITIVE14/09/18
IQN Application For Quotation of New Securities13/08/18
IQN Private Placement (Price Sensitive) PRICE SENSITIVE06/08/18
IQN IQNOVATE LTD INTENDS TO RE-DOMICILE TO USA (Price Sensitive) PRICE SENSITIVE01/08/18
IQN Chinese Patent Granted for Biosensor Platform (Price Sensitive) PRICE SENSITIVE02/07/18 download Created with Sketch. 609.86KB
IQN Application for Quotation of Additional Securities (Price Sensitive) PRICE SENSITIVE12/06/18 download Created with Sketch. 756.72KB
IQN Private Placement (Price Sensitive) PRICE SENSITIVE12/06/18 download Created with Sketch. 120.75KB
IQN Update on Saliva Glucose Biosensor & BioSensX (Price Sensitive) PRICE SENSITIVE06/06/18 download Created with Sketch. 247.35KB
IQN Application for Quotation of New Securities29/03/18
IQN Change in Substantial Shareholder29/03/18
IQN Change in Substantial Shareholder29/03/18
IQN Change in Directors' Interests29/03/18
IQN Half Yearly Accounts (Price Sensitive) PRICE SENSITIVE16/03/18
IQN Change of Address01/03/18
IQN Supplementary Trading Policy19/02/18
IQN Response to Query - Convertible Note Issue (Price Sensitive) PRICE SENSITIVE19/02/18
IQN Query - Convertible Note Issue (Price Sensitive) PRICE SENSITIVE19/02/18
IQN Application for Quotation of Additional Securities31/01/18
IQN Share Allotment & Cleansing Notice (Price Sensitive) PRICE SENSITIVE31/01/18
IQN NSX Price Query (Price Sensitive) PRICE SENSITIVE27/12/17
IQN Response to NSX Price Query (Price Sensitive) PRICE SENSITIVE27/12/17
IQN Closure of Convertible Note Issue22/12/17
IQN Results from 2017 AGM27/11/17
IQN 2017 Annual General Meeting Chairman's Address27/11/17
IQN Extension of Convertible Note Issue22/11/17
IQN Notice of 2017 Annual General Meeting27/10/17
IQN 2017 Annual Report (Price Sensitive) PRICE SENSITIVE20/10/17
IQN New License Agreement for MENA Region (Price Sensitive) PRICE SENSITIVE05/10/17
IQN IQN Preliminary Final Report and Financials for 30 June 2017 (Price Sensitive) PRICE SENSITIVE13/09/17
IQN Change of Company Auditor31/08/17
IQN Price Query - 3rd of August 201707/08/17
IQN Response to Price Query07/08/17
IQN Extension of Proposed Convertible Note Issue05/07/17
IQN 31 December 2016 Half Yearly Report (Price Sensitive) PRICE SENSITIVE16/03/17
IQN Extension to Convertible Note Private Placement07/03/17
IQN Results of 2016 Annual General Meeting18/11/16
IQN Removal of Trading Halt - Company to commence trading at 10.30am18/11/16
IQN Glucose Biosensor Systems (Greater China) (Price Sensitive) PRICE SENSITIVE18/11/16
IQN iQNovate Requests Trading Halt17/11/16
IQN iQnovate Notice of 2016 AGM17/10/16
IQN Share Placement Extended10/10/16
IQN 2016 Annual Report13/09/16
IQN Change of Company Secretary22/08/16
IQN Nominated Advisers Annual Statement to NSX21/07/16
IQN Application for Quotation of Addition Securities - Reorganisation of Capital13/07/16
IQN Results of Extraordinary General Meeting05/07/16
IQN Indicative Timetable for Proposed Share Split01/07/16
IQN Acquisition of Novel Glucose Biosensor (Price Sensitive) PRICE SENSITIVE29/06/16
IQN Notice of Extraordinary General Meeting06/06/16
IQN Listing of Wholly Owned Subsidiary13/05/16
IQN Intended Move to ASX27/04/16
IQN Extension of Private Placement Closing Date07/04/16
IQN Acquisition of oncology biologic compound (Price Sensitive) PRICE SENSITIVE05/04/16
IQN Financial Statements 31 December 201515/03/16
IQN Application for Quotation of Additional Securities18/12/15
IQN Change in Substantial Shareholder Interests18/12/15
IQN Change of Director's Interests18/12/15
IQN Change of Director's Interests18/12/15
IQN Results of 2015 Annual General Meeting17/11/15
IQN Amended Announcement – Iqnovate Ltd To Acquire Stake I17/11/15
IQN iQN Announcement of Emedia aquisition17/11/15
IQN Notice of Annual General Meeting28/10/15
IQN Extension of Private Placement Closing Date09/10/15
IQN iQnovate Ltd 2015 Annual Report (Price Sensitive) PRICE SENSITIVE11/09/15
IQN Closure of GXG Markets18/08/15
IQN Update - Nasdaq cross-listing14/08/15
IQN Listing of Wholly Owned Subsidiary22/05/15
IQN Change of Registry Address15/05/15
IQN iQnovate Ltd Half Yearly Report - 31 Dec 14 (Price Sensitive) PRICE SENSITIVE13/03/15
IQN Private Placement of the Company’s Shares13/03/15
IQN Listing of Wholly Owned Subsidiary11/03/15
IQN NASDAQ Cross-listing05/03/15
IQN Upgrade to OTCQB Marketplace26/02/15
IQN Application for quotation of securities23/12/14
IQN Exercise of Options23/12/14
IQN Notice of Final Director's Interests02/12/14
IQN Director Retirement02/12/14
IQN Results of 2014 AGM02/12/14
IQN 2014 IQN Notice of Annual General Meeting and Proxy29/10/14
IQN 2014 Annual Report (Price Sensitive) PRICE SENSITIVE12/09/14
IQN Application for Quotation of Additional Securities - Exercise of Options22/08/14
IQN Exercise of Options21/08/14
IQN Nominated Advisers Annual Statement to NSX18/08/14
IQN Change of Company Secretary24/07/14
IQN Application for Quotation of Exercised Options18/06/14
IQN Excercise of Options17/06/14
IQN Capital Raise02/05/14
IQN Half Yearly Financial Report (Price Sensitive) PRICE SENSITIVE14/03/14
IQN Application for Quotation of Exercised Options20/01/14
IQN IQNovate Half Yearly Report (Price Sensitive)
18/03/19PRICE SENSITIVE
IQN Price Query (Price Sensitive)
12/12/18PRICE SENSITIVE
IQN Response to Price Query (Price Sensitive)
12/12/18PRICE SENSITIVE
IQN General Market Disclosure (Price Sensitive)
28/11/18PRICE SENSITIVE
IQN Results of Meeting
27/11/18
IQN Chairman's Address
26/11/18
IQN Update to Scheme Implementation Dates
19/11/18
IQN Notice of 2018 AGM
26/10/18
IQN 2018 Annual Report (Price Sensitive)
30/09/18PRICE SENSITIVE
IQN Application for Securities
20/09/18
IQN Private Placement (Price Sensitive)
19/09/18PRICE SENSITIVE
IQN 2018 Preliminary Final Results & Financial Statements (Price Sensitive)
14/09/18PRICE SENSITIVE
IQN Application For Quotation of New Securities
13/08/18
IQN Private Placement (Price Sensitive)
06/08/18PRICE SENSITIVE
IQN IQNOVATE LTD INTENDS TO RE-DOMICILE TO USA (Price Sensitive)
01/08/18PRICE SENSITIVE
IQN Chinese Patent Granted for Biosensor Platform (Price Sensitive)
02/07/18PRICE SENSITIVE download Created with Sketch. 609.86KB
IQN Application for Quotation of Additional Securities (Price Sensitive)
12/06/18PRICE SENSITIVE download Created with Sketch. 756.72KB
IQN Private Placement (Price Sensitive)
12/06/18PRICE SENSITIVE download Created with Sketch. 120.75KB
IQN Update on Saliva Glucose Biosensor & BioSensX (Price Sensitive)
06/06/18PRICE SENSITIVE download Created with Sketch. 247.35KB
IQN Application for Quotation of New Securities
29/03/18
IQN Change in Substantial Shareholder
29/03/18
IQN Change in Substantial Shareholder
29/03/18
IQN Change in Directors' Interests
29/03/18
IQN Half Yearly Accounts (Price Sensitive)
16/03/18PRICE SENSITIVE
IQN Change of Address
01/03/18
IQN Supplementary Trading Policy
19/02/18
IQN Response to Query - Convertible Note Issue (Price Sensitive)
19/02/18PRICE SENSITIVE
IQN Query - Convertible Note Issue (Price Sensitive)
19/02/18PRICE SENSITIVE
IQN Application for Quotation of Additional Securities
31/01/18
IQN Share Allotment & Cleansing Notice (Price Sensitive)
31/01/18PRICE SENSITIVE
IQN NSX Price Query (Price Sensitive)
27/12/17PRICE SENSITIVE
IQN Response to NSX Price Query (Price Sensitive)
27/12/17PRICE SENSITIVE
IQN Closure of Convertible Note Issue
22/12/17
IQN Results from 2017 AGM
27/11/17
IQN 2017 Annual General Meeting Chairman's Address
27/11/17
IQN Extension of Convertible Note Issue
22/11/17
IQN Notice of 2017 Annual General Meeting
27/10/17
IQN 2017 Annual Report (Price Sensitive)
20/10/17PRICE SENSITIVE
IQN New License Agreement for MENA Region (Price Sensitive)
05/10/17PRICE SENSITIVE
IQN IQN Preliminary Final Report and Financials for 30 June 2017 (Price Sensitive)
13/09/17PRICE SENSITIVE
IQN Change of Company Auditor
31/08/17
IQN Price Query - 3rd of August 2017
07/08/17
IQN Response to Price Query
07/08/17
IQN Extension of Proposed Convertible Note Issue
05/07/17
IQN 31 December 2016 Half Yearly Report (Price Sensitive)
16/03/17PRICE SENSITIVE
IQN Extension to Convertible Note Private Placement
07/03/17
IQN Results of 2016 Annual General Meeting
18/11/16
IQN Removal of Trading Halt - Company to commence trading at 10.30am
18/11/16
IQN Glucose Biosensor Systems (Greater China) (Price Sensitive)
18/11/16PRICE SENSITIVE
IQN iQNovate Requests Trading Halt
17/11/16
IQN iQnovate Notice of 2016 AGM
17/10/16
IQN Share Placement Extended
10/10/16
IQN 2016 Annual Report
13/09/16
IQN Change of Company Secretary
22/08/16
IQN Nominated Advisers Annual Statement to NSX
21/07/16
IQN Application for Quotation of Addition Securities - Reorganisation of Capital
13/07/16
IQN Results of Extraordinary General Meeting
05/07/16
IQN Indicative Timetable for Proposed Share Split
01/07/16
IQN Acquisition of Novel Glucose Biosensor (Price Sensitive)
29/06/16PRICE SENSITIVE
IQN Notice of Extraordinary General Meeting
06/06/16
IQN Listing of Wholly Owned Subsidiary
13/05/16
IQN Intended Move to ASX
27/04/16
IQN Extension of Private Placement Closing Date
07/04/16
IQN Acquisition of oncology biologic compound (Price Sensitive)
05/04/16PRICE SENSITIVE
IQN Financial Statements 31 December 2015
15/03/16
IQN Application for Quotation of Additional Securities
18/12/15
IQN Change in Substantial Shareholder Interests
18/12/15
IQN Change of Director's Interests
18/12/15
IQN Change of Director's Interests
18/12/15
IQN Results of 2015 Annual General Meeting
17/11/15
IQN Amended Announcement – Iqnovate Ltd To Acquire Stake I
17/11/15
IQN iQN Announcement of Emedia aquisition
17/11/15
IQN Notice of Annual General Meeting
28/10/15
IQN Extension of Private Placement Closing Date
09/10/15
IQN iQnovate Ltd 2015 Annual Report (Price Sensitive)
11/09/15PRICE SENSITIVE
IQN Closure of GXG Markets
18/08/15
IQN Update - Nasdaq cross-listing
14/08/15
IQN Listing of Wholly Owned Subsidiary
22/05/15
IQN Change of Registry Address
15/05/15
IQN iQnovate Ltd Half Yearly Report - 31 Dec 14 (Price Sensitive)
13/03/15PRICE SENSITIVE
IQN Private Placement of the Company’s Shares
13/03/15
IQN Listing of Wholly Owned Subsidiary
11/03/15
IQN NASDAQ Cross-listing
05/03/15
IQN Upgrade to OTCQB Marketplace
26/02/15
IQN Application for quotation of securities
23/12/14
IQN Exercise of Options
23/12/14
IQN Notice of Final Director's Interests
02/12/14
IQN Director Retirement
02/12/14
IQN Results of 2014 AGM
02/12/14
IQN 2014 IQN Notice of Annual General Meeting and Proxy
29/10/14
IQN 2014 Annual Report (Price Sensitive)
12/09/14PRICE SENSITIVE
IQN Application for Quotation of Additional Securities - Exercise of Options
22/08/14
IQN Exercise of Options
21/08/14
IQN Nominated Advisers Annual Statement to NSX
18/08/14
IQN Change of Company Secretary
24/07/14
IQN Application for Quotation of Exercised Options
18/06/14
IQN Excercise of Options
17/06/14
IQN Capital Raise
02/05/14
IQN Half Yearly Financial Report (Price Sensitive)
14/03/14PRICE SENSITIVE
IQN Application for Quotation of Exercised Options
20/01/14
refresh Created with Sketch. REFRESH
 

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.